A real-world, multi-center, prospective, observational study for PNH in China - ReWoPNH

Study identifier:D7414R00001

ClinicalTrials.gov identifier:NCT06154512

EudraCT identifier:N/A

CTIS identifier:N/A

Recruitment Complete

Official Title

A real-world, multi-center, prospective, observational study for Paroxysmal Nocturnal Haemoglobinuria (PNH) in China

Medical condition

paroxysmal nocturnal hemoglobinuria

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

724

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 10 Nov 2023
Estimated Primary Completion Date: 30 Nov 2025
Estimated Study Completion Date: 30 Nov 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria